Screening and the costs of treating colorectal cancer.
The objective of this paper is to compare the hospital costs of treating patients with colorectal cancers detected as a result of a faecal occult blood screening programme with those of patients whose cancers present symptomatically (control group).
Patient-specific cost estimates are made, using case records and hospital accounts, for 360 patients over 3 years.
Mean treatment costs for the group offered screening and for the control group are calculated to be £3,179 and £2,966 respectively, although the difference between these means is insignificant.
Low treatment costs in the case of screen-detected cancers are largely accounted for by polypectomy with no subsequent readmission; in the control group case, they tend to be accounted for by early patient death.
Mots-clés Pascal : Tumeur maligne, Côlon, Rectum, Chirurgie, Analyse coût, Economie santé, Dépistage, Royaume Uni, Europe, Homme, Côlon pathologie, Rectum pathologie, Intestin pathologie, Appareil digestif pathologie, Traitement
Mots-clés Pascal anglais : Malignant tumor, Colon, Rectum, Surgery, Cost analysis, Health economy, Medical screening, United Kingdom, Europe, Human, Colonic disease, Rectal disease, Intestinal disease, Digestive diseases, Treatment
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0110286
Code Inist : 002B13B01. Création : 199406.